CBT-I with Melatonin for Older Adults with Chronic Insomnia
Official title: Efficacy of Cognitive Behavioural Therapy for Insomnia With Adjuvant Melatonin Treatment in Older Adults With Chronic Insomnia: A Randomised Controlled Trial
Run by The University of Hong Kong · NCT07695246 · Data updated 2026-11-12
In people aged 60 and over with chronic insomnia, researchers will test whether CBT-I plus nightly melatonin helps sleep better than CBT-I with a placebo or sleep-health education with placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 183 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | August 1, 2029 |
| Study ends | August 1, 2029 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07695246 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Chinese adults aged 60 or older diagnosed with insomnia disorder (DSM-5) and ISI > 14, willing to participate in four weekly group sessions.
✕Probably not a fit
Patients whose insomnia is primarily caused by other sleep disorders or medical conditions may derive limited or no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind study will compare three groups over four weeks: CBT-I with melatonin, CBT-I with placebo, and sleep-health psychoeducation with placebo. Participants will complete sleep diaries, questionnaires, actigraphy, and polysomnography to measure sleep, circadian rhythm, mood, fatigue, and cognitive function. Assessments occur at baseline, mid-treatment, post-treatment, and follow-ups at three and six months for the CBT-I groups. The study will recruit adults 60+ with DSM-5 insomnia disorder and ISI scores above 14, and will use 3 mg immediate-release melatonin or matched placebo taken 30 minutes before bedtime.
Why it matters
Potential benefit: If successful, the approach could offer a more effective treatment option for improving sleep and daytime functioning in older adults with insomnia.
How similar studies have gone: Previous CBT-I studies show benefit for insomnia; adding melatonin is being tested for potential added improvement in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Chinese aged ≥ 60. 2. Provision of written informed consent. 3. Having a DSM-5 diagnosis of insomnia disorder (i.e., having difficulty initiating sleep, maintaining sleep, or early morning awakening at least three times a week for at least three months, with clinically significant impairment or distress). 4. Having a score of \> 14 on the ISI, indicating clinical insomnia. Exclusion Criteria: 1. Having a current diagnosis or a history of manic or hypomanic episodes, schizophrenia spectrum disorders, neurodevelopmental disorders, neurocognitive disorders, organic mental disorders, intellectual disabilities, or substance abuse or dependence. 2. Having a progressive medical condition directly related to the onset and course of insomnia (e.g., cancer, chronic pain). 3. Undergoing treatment for diseases known to affect sleep (e.g., chemotherapy). 4. Having an untreated sleep disorder that may disrupt sleep continuity and quality (e.g., sleep-disordered breathing) except for insomnia disorder. 5. Having mild to significant cognitive impairment, defined by having a score of \< 22 on MOCA. 6. Concurrent and regular use of extraneous melatonin or melatonin agonist (e.g., ramelteon). 7. Receiving concurrent psychological treatment for insomnia. 8. Meeting potential contraindications for melatonin (e.g., undergoing dialysis) or concurrently using medications that have a potential drug interaction with melatonin (e.g., anticoagulant and anti-platelet). 9. Being a night shift worker.
Where it's running
-
Sleep Research Clinic and Laboratory, Department of Psychology, The University of Hong Kong
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Shirley Xin LI, DClinPsy, PhD
- Email: shirleyx@hku.hk
- Phone: 852 39177035
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Aquatic power training dosing strategies and creatine in older adults
This trial tests whether different aquatic power training dosing methods and creatine supplementation help improve function in community-dwelling adults aged 60 and older.
-
Intergenerational Interaction Program for Nursing Home Residents and Nursing Students
A 6-week program pairs nursing home residents with nursing students to see if weekly joint activities can increase joy and reduce loneliness for older adults and lessen ageism in students.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Berobenatide in adults with sleep apnea and obesity who don’t use a PAP machine
This study tests berobenatide versus placebo in adults with moderate-to-severe obstructive sleep apnea and overweight or obesity who are not using PAP therapy.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.